Formulation and process considerations for beads containing Carbopol® 974P, NF resin made by extrusion-spheronization

International Journal of Pharmaceutics

Volumn 199, Issue 2, 2000, Pages 129-140

  Neau, Steven H ^a   Chow, Michelle Y ^b   Hileman, Gregory A ^c   Durrani, Manzer J ^d   Gheyas, Ferdous ^e   Evans, Barry A ^c  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b Sun Valley Research Inc   (Canada)

^c GLAXOSMITHKLINE   (United States)

^d Primedica   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Beads; Carbomer; Carbopol; Extrusion spheronization; Pellets; Statistical design

Indexed keywords

CALCIUM CHLORIDE; CARBOMER; CHLORPHENIRAMINE MALEATE; MICROCRYSTALLINE CELLULOSE; RESIN;

ARTICLE; CONCENTRATION RESPONSE; DRUG FORMULATION; DRUG MANUFACTURE; DRUG RELEASE; DRUG SOLUBILITY; PELLET EXTRUSION; PRIORITY JOURNAL; SPHERONIZATION; WATER CONTENT;

ACRYLATES; CHEMISTRY, PHARMACEUTICAL; MICROSPHERES; WATER;

EID: 0034690019     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(00)00372-0     Document Type: Article

References (12)

1. Carbopol® Resin Handbook, 1993. BFGoodrich, Cleveland, OH.
2. Choulis N.H., Papadopoulos H. Time-release tablets containing quinine sulfate. J. Pharm. Sci. 64:1975;1033-1035.
3. Choulis N.H., Papadopoulos H., Choulis M. Long acting methadone. Pharmazie. 31:1976;466-470.
4. Durrani M.J., Todd R., Andrews A., Whitaker R.W., Greenberg E., Benner S.C. Polymer concentration effects on Carbopol 934P tablets for controlled release. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 19:1992;411-412.
5. Elsabbagh H., Sakr A., Abd-Elhadi S. Effect of guar gum on the dissolution rate of ephedrine hydrochloride and sulphadimidine tablets. Pharmazie. 33:1978;730-731.
6. Fielden K.E., Newton J.M., Rowe R.C. A comparison of the extrusion and spheronization behaviour of wet powder masses processed by a ram extruder and a cylinder extruder. Int. J. Pharm. 81(1993):1993;225-233.
7. Goskonda S.R., Hileman G.A., Upadrashta S.M. Controlled release pellets by extrusion-spheronization. Int. J. Pharm. 111:1994;89-97.
8. Harrison P.J., Newton J.M., Rowe R.C. The characterization of wet powder masses suitable for extrusion/spheronization. J. Pharm. Pharmacol. 37:1985;686-691.
9. Hasznos L., Langer I., Gyarmathy M. Some factors influencing pellet characteristics made by an extrusion/spheronization process. Drug Dev. Ind. Pharm. 18:1992;409-437.
10. Hicks D.C., Freese H.L. Extrusion and spheronizing. Ghebre-Sellassie I. Pharmaceutical Pelletization Technology. 1989;71-100 Marcel Dekker, New York.
11. Neau S.H., Chow M.Y., Durrani M.J. Fabrication and characterization of extruded and spheronized beads containing Carbopol® 974P, NF resin. Int. J. Pharm. 131:1996;47-55.
12. Woodruff C.W., Nuessle N.O. Effect of processing variables on particles obtained by extrusion-spheronization processing. J. Pharm. Sci. 61:1972;787-790.